• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小肠癌伴广泛淋巴结转移经甲氨蝶呤/5-氟尿嘧啶序贯治疗后完全缓解:病例报告

Small intestinal cancer with extensive lymph node metastases showing complete remission by methotrexate/5-fluorouracil sequential therapy: report of a case.

作者信息

Onodera H, Nishitai R, Shimizu K, Maetani S, Imamura M

机构信息

First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.

出版信息

Surg Today. 1997;27(1):60-3. doi: 10.1007/BF01366941.

DOI:10.1007/BF01366941
PMID:9035302
Abstract

A case of poorly differentiated adenocarcinoma of the small bowel with extensive lymph node metastases is herein presented, which responded to methotrexate/5-fluorouracil (MTX/5-FU) sequential therapy. The lymph node metastases disappeared completely after 10 months of treatment. After recurrence, combination therapy with radiation, hyperthermia, and cisplatinum were also effective in reducing the degree of nodal swelling while still allowing the patient to maintain her accustomed lifestyle for a prolonged period of time. Further multi-institutional studies are still needed, however, to fully assess this new therapeutic regimen for small bowel cancers.

摘要

本文报告一例小肠低分化腺癌伴广泛淋巴结转移患者,其对甲氨蝶呤/5-氟尿嘧啶(MTX/5-FU)序贯疗法有反应。治疗10个月后,淋巴结转移完全消失。复发后,放疗、热疗和顺铂联合治疗在减轻淋巴结肿大程度方面也有效,同时仍能使患者长时间维持其习惯的生活方式。然而,仍需要进一步的多机构研究来全面评估这种针对小肠癌的新治疗方案。

相似文献

1
Small intestinal cancer with extensive lymph node metastases showing complete remission by methotrexate/5-fluorouracil sequential therapy: report of a case.小肠癌伴广泛淋巴结转移经甲氨蝶呤/5-氟尿嘧啶序贯治疗后完全缓解:病例报告
Surg Today. 1997;27(1):60-3. doi: 10.1007/BF01366941.
2
[Advanced gastric carcinoma with extensive lymph node metastases successfully treated by sequential methotrexate/5-fluorouracil therapy].
Gan To Kagaku Ryoho. 1995 Jul;22(8):1107-10.
3
[A case of papillary adenocarcinoma of the stomach with liver metastases and carcinomatous peritonitis treated effectively by methotrexate/5-fluorouracil sequential chemotherapy].
Gan To Kagaku Ryoho. 1997 Oct;24(13):2005-9.
4
[Sequential chemotherapy with methotrexate and 5-fluorouracil for advanced gastric cancer].[甲氨蝶呤与5-氟尿嘧啶序贯化疗用于晚期胃癌]
Gan To Kagaku Ryoho. 1998 Mar;25(4):541-6.
5
[A case of rectal cancer with distant lymph node metastases completely responding to postoperative chemotherapy with levofolinate combined with 5-fluorouracil].[一例伴有远处淋巴结转移的直肠癌患者对左亚叶酸联合5-氟尿嘧啶术后化疗完全缓解]
Gan To Kagaku Ryoho. 2004 Jan;31(1):117-9.
6
[A case of advanced gastric cancer with DIC treated by sequential MTX and 5-FU].[1例晚期胃癌合并弥散性血管内凝血经甲氨蝶呤和5-氟尿嘧啶序贯治疗的病例]
Gan To Kagaku Ryoho. 2004 Mar;31(3):399-401.
7
[A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].[1例伴胸膜炎、腹膜播散及库肯勃瘤的4型胃癌经甲氨蝶呤、氟尿嘧啶及低剂量顺铂联合化疗(MFP方案)后生存3年4个月的病例]
Gan To Kagaku Ryoho. 2006 Nov;33(11):1641-4.
8
[Two cases of gastrointestinal cancers with major responses to sequential methotrexate 5-FU plus 5'-DFUR].两例胃肠道癌对序贯使用甲氨蝶呤、5-氟尿嘧啶加去氧氟尿苷有显著反应
Gan To Kagaku Ryoho. 1989 May;16(5):2109-12.
9
[A case of gastric cancer completely responding to sequential methotrexate and 5-fluorouracil therapy].
Gan To Kagaku Ryoho. 1994 Sep;21(12):2035-8.
10
[A case of nonresectable gastric cancer treated by sequential methotrexate and 5-fluorouracil].[一例采用甲氨蝶呤与5-氟尿嘧啶序贯治疗的不可切除胃癌病例]
Gan To Kagaku Ryoho. 1994 Jan;21(1):103-6.

引用本文的文献

1
Irinotecan-based combination chemotherapy for metastatic small intestinal adenocarcinoma.基于伊立替康的联合化疗用于转移性小肠腺癌
Oncol Lett. 2010 May;1(3):423-426. doi: 10.3892/ol_00000074. Epub 2010 May 1.
2
Chemotherapy for small-bowel Adenocarcinoma at a single institution.单机构小肠腺癌的化疗
Surg Today. 2009;39(1):27-31. doi: 10.1007/s00595-008-3843-2. Epub 2009 Jan 8.
3
Resection of small bowel adenocarcinoma liver metastasis combined with neoadjuvant and adjuvant chemotherapy results in extended disease-free period--a case report.

本文引用的文献

1
Adenocarcinoma of the small intestine: a plea for early diagnosis.小肠腺癌:呼吁早期诊断。
South Med J. 1993 Sep;86(9):1067-9. doi: 10.1097/00007611-199309000-00021.
2
Drug resistance: genotype versus phenotype--thirty-second G. H. A. Clowes Memorial Award Lecture.耐药性:基因型与表型——第32届G. H. A. 克劳斯纪念奖讲座
Cancer Res. 1994 Feb 1;54(3):666-78.
3
The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice.p53在正常小鼠和p53基因缺陷小鼠胃肠道的自发凋亡及辐射诱导凋亡中的作用。
小肠腺癌肝转移切除联合新辅助化疗和辅助化疗可延长无病生存期——1例病例报告
Int J Gastrointest Cancer. 2006;37(2-3):94-7. doi: 10.1007/s12029-007-0005-5.
Cancer Res. 1994 Feb 1;54(3):614-7.
4
How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.癌细胞如何逃避化疗:第十六届理查德与欣达·罗森塔尔基金会奖讲座
Cancer Res. 1993 Feb 15;53(4):747-54.
5
Malignant tumours of the small bowel.小肠恶性肿瘤
Surg Oncol. 1994 Apr;3(2):61-8. doi: 10.1016/0960-7404(94)90001-9.
6
Adenocarcinoma of the small intestine.小肠腺癌
Am J Surg. 1984 Jan;147(1):66-71. doi: 10.1016/0002-9610(84)90036-9.
7
Chemotherapy for primary adenocarcinoma of the small bowel.小肠原发性腺癌的化疗
Cancer. 1984 Jan 1;53(1):23-5. doi: 10.1002/1097-0142(19840101)53:1<23::aid-cncr2820530106>3.0.co;2-u.
8
5-fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyridylate binding to thymidylate synthase by dihydropteroylpolyglutamates.5-氟尿嘧啶-甲氨蝶呤协同作用:二氢蝶酰多聚谷氨酸增强5-氟脱氧尿苷酸与胸苷酸合成酶的结合
Proc Natl Acad Sci U S A. 1980 Oct;77(10):5663-7. doi: 10.1073/pnas.77.10.5663.
9
Primary malignancies of the small bowel: a report of 96 cases and review of the literature.小肠原发性恶性肿瘤:96例报告并文献复习
Ann Surg. 1974 Aug;180(2):175-9. doi: 10.1097/00000658-197408000-00008.
10
Why are small-bowel tumours so rare?为什么小肠肿瘤如此罕见?
Lancet. 1973 Jan 6;1(7793):24-6. doi: 10.1016/s0140-6736(73)91228-2.